BRNS

BARINTHUS BIOTHERAPEUTICS PL

BRNS·91864C107·US·ADR·Healthcare - Biotechnology-Activist

BRNS (BARINTHUS BIOTHERAPEUTICS PL) is held by 8 institutional investors as of Q1 2026. Largest holders: M&G Plc ($5.2M), RENAISSANCE TECHNOLOGIES LLC ($85,919), CITADEL ADVISORS LLC ($68,125). Net institutional sentiment: Mixed.

8
Holders
Avg rating(3 Elite)
$5.4M
Total Value
50% (9)
Fund Consensus
2 buying - 2 selling
BRNSSmart Money Verdict
View all
Held by 8 funds
3 elite
Who's Trading
ActivistIGInternational Generosity Foundation Trust6.7%Apr 13, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
5.2M$5.2M0.0%-73.11%
0
Increased
151,000(+5.5%)$85,9190.0%-46.18%
23
Increased
118,996(+0.2%)$68,1250.0%-5.87%
14
Unchanged
105,961$60,2920.0%-55.08%
0
Unchanged
37,450$21,3090.0%-39.05%
0
Unchanged
11,685$6,6830.0%-5.88%
0
Unchanged
11,568$6,6220.0%-82.66%
0
Decreased
2,210(-35.1%)$1,2580.0%-36.30%
0
Exited
0(-100.0%)$2,2060.0%-12.19%
0

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used